{"disease":{"id":"alsp","name":"alsp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT02699190","title":"LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies","phase":"","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT05020743","title":"Natural History Study in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia","phase":"","overall_status":"TERMINATED","enrollment_count":56,"lead_sponsor_name":"Vigil Neuroscience, Inc.","has_results":true},{"nct_id":"NCT05677659","title":"A Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"Vigil Neuroscience, Inc.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}